Latest News

New partner initiative for Adherium August 22, 2019

Australian respiratory medical device company Adherium (ASX:ADR) has announced a new strategic data-based initiative with Summatix.

Opal to participate in ARC-funded 'Hub' August 22, 2019

Australian infectious disease therapy company Opal Biosciences has announced its participation in the successful Australian Research Council (ARC) Research Hub to Combat Antimicrobial Resistance.

Noxopharm updates on Veyonda proof-of-principle experiments August 22, 2019

Noxopharm (ASX:NOX) has provided an update on results from a series of proof-of-principle experiments in mice that are exploring the interaction between Veyonda and radiotherapy in a novel treatment regimen known as DARRT.

Pfizer to invest US$500m in gene therapy manufacturing August 22, 2019

Pfizer has accelerated its move into new technologies, announcing it will invest US$500 million in the construction of a gene therapy manufacturing facility in the US.

Last call for Early Stage Investment Forum August 22, 2019

AusBiotech is calling for early-stage projects to register for their Early Stage Investment Forum with submissions closing Friday 30 August.

Starpharma announces first regulatory approval in Asia for VivaGel BV August 20, 2019

According to Starpharma CEO, Dr Jackie Fairley, “We are very pleased to receive our first regulatory approvals of VivaGel BV in Asia."

Cochlear delivers positive outlook for implant growth August 20, 2019

Cochlear (ASX:COH) has announced its full-year 2019 result with sales revenue up 7 per cent to $1.446 billion and net profit up 13 per cent to $276.7 million.

Telix updates on Share Purchase Plan August 20, 2019

Telix Pharmaceuticals (ASX:TLX) has announced subscriptions under its Share Purchase Plan (SPP) totalled approximately $9.6 million.

Race announces successful completion of placement August 20, 2019

Race Oncology (ASX:RAC) has announced the successful completion of a $1.45 million placement, led by biotechnology investor Dr Daniel Tillett.

Sydney-based Noxopharm looking to make 'cold' tumours 'hot' August 15, 2019

Sydney-based company Noxopharm is developing a new approach to cancer treatment that is designed to convert 'cold' tumours to 'hot' so they can be recognised by the immune system.

Greg Hunt launches 'Long Term National Health Plan' August 15, 2019

Health minister Greg Hunt has announced a new national health plan that features a strong emphasis on medical research.

CSL reports higher revenue and profit August 15, 2019

CSL has announced a strong full-year result with net profit after tax up 17 per cent to US$1.919 billion on the back of an 11 per cent jump in revenue.

Most Read

New Stories

New partner initiative for Adherium

Opal to participate in ARC-funded 'Hub'

Noxopharm updates on Veyonda proof-of-principle experiments

Pfizer to invest US$500m in gene therapy manufacturing

Last call for Early Stage Investment Forum

Starpharma announces first regulatory approval in Asia for VivaGel BV

Cochlear delivers positive outlook for implant growth

Sign In